Hammerson PLC
20 November 2002
Spitalfields Scheme Planning Consent
Further to the announcement made on 10 October 2002, detailed planning consent
has been granted for the redevelopment of Bishops Square, London E1. The consent
follows the decision of the Mayor of London and the Secretary of State for the
Environment to allow the local authority, The London Borough of Tower Hamlets,
to issue the consent it had resolved to grant in October.
The development will be undertaken by Spitalfields Development Group ('SDG'),
which is now wholly owned by Hammerson plc, working with The Corporation of
London. Hammerson's share of the estimated total development cost is £285
million.
Designed by Foster & Partners, Bishops Square will consist of 70,000 m(2)
(750,000 ft(2)) of offices, 4,000 m(2) (45,000 ft(2)) of retail accommodation,
extensive public space and amenities. It is anticipated that the 21/4 year
construction programme, to be undertaken by Sir Robert McAlpine, will begin
early in 2003. A lease of the entire building has been agreed with leading
international law firm, Allen & Overy.
For further information:
John Richards Tel: 020 7887 1000
Chief Executive Fax: 020 7887 1010
Hammerson plc
Christopher Smith
Director of Corporate Affairs
Hammerson plc
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.